DE69926776D1 - Quinalozinon-derivate - Google Patents

Quinalozinon-derivate

Info

Publication number
DE69926776D1
DE69926776D1 DE69926776T DE69926776T DE69926776D1 DE 69926776 D1 DE69926776 D1 DE 69926776D1 DE 69926776 T DE69926776 T DE 69926776T DE 69926776 T DE69926776 T DE 69926776T DE 69926776 D1 DE69926776 D1 DE 69926776D1
Authority
DE
Germany
Prior art keywords
hydrogen atom
alkyl group
äwherein
chem
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69926776T
Other languages
English (en)
Other versions
DE69926776T2 (de
Inventor
Masami Muraoka
Kazuki Matsui
Koji Morishita
Naohito Ohashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Pharma Co Ltd
Original Assignee
Sumitomo Pharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Pharmaceuticals Co Ltd filed Critical Sumitomo Pharmaceuticals Co Ltd
Publication of DE69926776D1 publication Critical patent/DE69926776D1/de
Application granted granted Critical
Publication of DE69926776T2 publication Critical patent/DE69926776T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69926776T 1998-10-16 1999-10-07 Quinalozinon-derivate Expired - Lifetime DE69926776T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP29505098 1998-10-16
JP29505098 1998-10-16
PCT/JP1999/005560 WO2000023436A1 (fr) 1998-10-16 1999-10-07 Derives de quinazolinone

Publications (2)

Publication Number Publication Date
DE69926776D1 true DE69926776D1 (de) 2005-09-22
DE69926776T2 DE69926776T2 (de) 2006-06-08

Family

ID=17815680

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69926776T Expired - Lifetime DE69926776T2 (de) 1998-10-16 1999-10-07 Quinalozinon-derivate

Country Status (10)

Country Link
US (1) US6645971B1 (de)
EP (1) EP1122253B1 (de)
JP (1) JP4484368B2 (de)
KR (1) KR100607634B1 (de)
AT (1) ATE302199T1 (de)
CA (1) CA2347506C (de)
DE (1) DE69926776T2 (de)
ES (1) ES2244243T3 (de)
PT (1) PT1122253E (de)
WO (1) WO2000023436A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4087337B2 (ja) * 2001-08-09 2008-05-21 大日本住友製薬株式会社 キナゾリノン誘導体
CA2550650A1 (en) * 2003-12-23 2005-07-14 Darpharma, Inc. Co-administration of dopamine-receptor binding compounds
JP4643948B2 (ja) * 2004-08-23 2011-03-02 大日本住友製薬株式会社 キナゾリノン化合物の安定化方法
JP4667789B2 (ja) * 2004-08-23 2011-04-13 大日本住友製薬株式会社 キナゾリノン化合物の酸付加塩の製造方法
US20090275574A1 (en) * 2008-05-05 2009-11-05 Astrazeneca Ab Novel compounds-300
CA2743562C (en) 2008-11-20 2014-03-18 Merck Sharp & Dohme Corp. Aryl methyl benzoquinazolinone m1 receptor positive allosteric modulators
US8664387B2 (en) 2009-12-14 2014-03-04 Merck Sharp & Dohme Corp. Pyridoquinazolinone M1 receptor positive allosteric modulators
WO2011084371A1 (en) * 2009-12-21 2011-07-14 Merck Sharp & Dohme Corp. Aminobenzoquinazolinone m1 receptor positive allosteric modulators
US11685729B2 (en) 2018-01-19 2023-06-27 Idorsia Pharmaceuticals Ltd. C5a receptor modulators
CN111615513A (zh) 2018-01-19 2020-09-01 爱杜西亚药品有限公司 C5a受体调节剂

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3819627A (en) * 1968-07-01 1974-06-25 Sandoz Ag 1-substituted-3,4-dihydro-2(1h)-quinazolinones
JPS4822716B1 (de) * 1968-07-01 1973-07-07
FR2027023A1 (en) * 1968-12-24 1970-09-25 Farmaceutici Italia Substd quinazoline derivs prepn cns depress - ants
US3547921A (en) 1968-12-26 1970-12-15 Sandoz Ag Preparation of 1-substituted-4-aryl-3,4-dihydro-2(1h)-quinazolinones
JPS4834598B1 (de) * 1970-12-23 1973-10-22
US3829420A (en) 1970-07-13 1974-08-13 Sumitomo Chemical Co 3,4-dihydro-2(1h)-quinazolinones and preparation thereof
AU438472B2 (en) * 1970-12-23 1973-08-09 Sumitomo Chemical Company, Limited Quinazolinone derivatives anda process for production thereof
US4099002A (en) 1970-12-23 1978-07-04 Sumitomo Chemical Company, Limited Quinazolinone derivatives and a process for production thereof
BE795519A (fr) * 1972-02-18 1973-06-18 Sumitomo Chemical Co Procede de preparation d'un agent uricosurique
US3812257A (en) * 1972-04-07 1974-05-21 Sumitomo Chemical Co Uricosuric agent
JPS4925270B1 (de) * 1973-04-09 1974-06-28
US4335127A (en) * 1979-01-08 1982-06-15 Janssen Pharmaceutica, N.V. Piperidinylalkyl quinazoline compounds, composition and method of use
JPS56113769A (en) * 1980-02-13 1981-09-07 Sumitomo Chem Co Ltd Novel 2 1h -quinazolinone derivative and its preparation
JPS5795966A (en) * 1980-12-04 1982-06-15 Sumitomo Chem Co Ltd Novel 2(1h)-quinazolinone derivative
JP3859738B2 (ja) 1993-05-26 2006-12-20 大日本住友製薬株式会社 キナゾリノン誘導体
CA2124306C (en) 1993-05-26 2004-04-06 Masami Muraoka Quinazolinone derivatives

Also Published As

Publication number Publication date
EP1122253A1 (de) 2001-08-08
US6645971B1 (en) 2003-11-11
PT1122253E (pt) 2005-11-30
KR100607634B1 (ko) 2006-08-02
CA2347506A1 (en) 2000-04-27
WO2000023436A1 (fr) 2000-04-27
ES2244243T3 (es) 2005-12-01
ATE302199T1 (de) 2005-09-15
CA2347506C (en) 2009-06-23
DE69926776T2 (de) 2006-06-08
KR20010080159A (ko) 2001-08-22
JP4484368B2 (ja) 2010-06-16
EP1122253A4 (de) 2003-05-28
EP1122253B1 (de) 2005-08-17

Similar Documents

Publication Publication Date Title
DE60315265D1 (de) Stickstoffhaltige heterocyclische verbindung und arzneimittel davon
ID17851A (id) Persenyawaan heterosiklis, produksi dan pemakaiannya
BR0002936A (pt) Compostos de biciclicarbonil-indol como agentes antiinflamatórios/analgésicos
ATE339409T1 (de) Trizyklische verbindungen
DK0625977T3 (da) Piperazinderivater som 5-1A-antagonister
FI972460A0 (fi) Aniliinijohdannaiset joilla on typpimonoksidisyntaasiesto aktiivisuus
DK0790987T3 (da) Aminotetrazol-derivater, der er anvendelige som nitrogenoxidsynthaseinhibitorer
ATE302199T1 (de) Quinalozinon-derivate
ATE172463T1 (de) Pyrrolocarbazol
DE69617226D1 (de) Piperidinderivate.
IL136510A0 (en) Acylated hetero-alicyclic derivatives and pharmaceutical compositions containing the same
EP1197211A4 (de) Wirkstoffe zur vorbeugung und behandlung von krebs
EP1340753A4 (de) Carbamatderivate, verfahren zu deren herstellung und deren verwendung
DE60103732D1 (de) Pyrimidinderivate mit antitumor-wirkung

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: DAINIPPON SUMITOMO PHARMA CO., LTD., OSAKA, JP

8364 No opposition during term of opposition